Efficacy and Safety of Fractional 1064-nm Picosecond Laser for Facial Skin Tightening

Laxity; Skin Clinical Trial

Official title: Efficacy and Safety of Fractional 1064-nm Picosecond Laser for Facial Skin Tightening

Status Recruiting

Clinical Trial Summary

The goal of this clinical trial is to learn the efficacy and safety of fractional 1064-nm picosecond laser for facial skin tightening. The main questions it aims to answer are:

• Efficacy of fractional 1064-nm picosecond laser for facial skin efficacy including the changes in wrinkle, nasolabial fold, skin laxity, and skin elasticity

• The changes in texture and pore volume using Antera

• The changes in bioengineering assessment: melanin index, erythema index, sebum level

• Adverse events Participants will be treated with 3 sessions of fractional 1064-nm picosecond laser (full face 4 passes, vector lines 4 passes), spaced 4 weeks apart. Follow-up visits 1, 3, and 6 months after the last treatments.

Clinical Trial Description

The efficacy and safety of fractional 1064-nm picosecond laser for facial skin tightening in participants aged 40 to 55 years, BMI < 25 kg/m2, and have mild to moderate facial laxity. ;

Related Conditions & MeSH terms

• Cutis Laxa
• Laxity; Skin

• NCT number: NCT06231914
• Study type: Interventional
• Source: Mahidol University
• Contact: Woraphong Manuskiatti, MD
• Phone: 6624194333
• Email: doctorlaser@gmail.com
• Status: Recruiting
• Phase: N/A
• Start date: December 1, 2023
• Completion date: March 1, 2025